MannKind Corp. (MNKD)
3.38
+0.07
(+2.11%)
USD |
NASDAQ |
May 22, 16:00
3.385
0.00 (0.00%)
After-Hours: 20:00
MannKind EPS Diluted (Quarterly) : -0.0539 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Therapeutics Corp. | 5.824 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Insmed, Inc. | -0.7591 |
| Agios Pharmaceuticals, Inc. | -1.686 |
| ADMA Biologics, Inc. | 0.1889 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.62M |
| Revenue (Quarterly) | 90.17M |
| Total Expenses (Quarterly) | 106.79M |
| Enterprise Value | 1.347B |
| Gross Profit Margin (Quarterly) | 75.78% |
| Profit Margin (Quarterly) | -18.43% |
| Earnings Yield | -2.31% |
| Operating Earnings Yield | 2.37% |
| Normalized Earnings Yield | -1.231 |